Sartorius AG (SARTF)
SARTF Stock Price Chart
Explore Sartorius AG interactive price chart. Choose custom timeframes to analyze SARTF price movements and trends.
SARTF Company Profile
Discover essential business fundamentals and corporate details for Sartorius AG (SARTF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
22 Sept 2010
Employees
13.57K
Website
https://www.sartorius.comCEO
Joachim Kreuzburg
Description
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
SARTF Financial Timeline
Browse a chronological timeline of Sartorius AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 14 Apr 2026
Upcoming earnings on 26 Jan 2026
Upcoming earnings on 16 Oct 2025
Revenue estimate is $982.90M.
Earnings released on 22 Jul 2025
EPS came in at $1.38 falling short of the estimated $1.53 by -9.80%, while revenue for the quarter reached $1.04B , beating expectations by +6.20%.
Earnings released on 16 Apr 2025
EPS came in at $1.28 matching the estimated $1.28, while revenue for the quarter reached $967.99M , missing expectations by -6.20%.
Earnings released on 17 Feb 2025
EPS came in at $1.11 falling short of the estimated $1.17 by -5.13%, while revenue for the quarter reached $938.98M , beating expectations by +7.70%.
Dividend declared on 23 Jan 2025
A dividend of $0.79 per share was announced, adjusted to $0.85. The dividend was paid on 1 Apr 2025.
Earnings released on 17 Oct 2024
EPS came in at $0.96 surpassing the estimated $0.96 by +0.42%, while revenue for the quarter reached $870.36M , missing expectations by -4.06%.
Earnings released on 18 Jul 2024
EPS came in at $1.23 surpassing the estimated $1.05 by +17.14%, while revenue for the quarter reached $925.46M , beating expectations by +2.50%.
Earnings released on 18 Apr 2024
EPS came in at $1.10 falling short of the estimated $1.19 by -7.56%, while revenue for the quarter reached $880.48M , missing expectations by -5.34%.
Earnings released on 16 Feb 2024
EPS came in at $1.01 falling short of the estimated $1.31 by -22.90%, while revenue for the quarter reached $934.57M , beating expectations by +1.44%.
Dividend declared on 2 Feb 2024
A dividend of $0.79 per share was announced, adjusted to $0.85. The dividend was paid on 4 Apr 2024.
Earnings released on 19 Oct 2023
EPS came in at $1.13 falling short of the estimated $1.48 by -23.65%, while revenue for the quarter reached $855.16M , missing expectations by -4.99%.
Earnings released on 21 Jul 2023
EPS came in at $1.37 falling short of the estimated $1.78 by -23.03%, while revenue for the quarter reached $907.64M , missing expectations by -3.33%.
Earnings released on 20 Apr 2023
EPS came in at $1.81 falling short of the estimated $2.50 by -27.60%, while revenue for the quarter reached $981.97M , missing expectations by -12.99%.
Earnings released on 17 Feb 2023
EPS came in at $2.37 surpassing the estimated $1.79 by +32.40%, while revenue for the quarter reached $1.14B , beating expectations by +3.23%.
Dividend declared on 17 Feb 2023
A dividend of $1.56 per share was announced, adjusted to $1.67. The dividend was paid on 3 Apr 2023.
Earnings released on 19 Oct 2022
EPS came in at $2.41 surpassing the estimated $2.24 by +7.59%, while revenue for the quarter reached $1.03B , missing expectations by -0.97%.
Earnings released on 21 Jul 2022
EPS came in at $2.49 surpassing the estimated $2.31 by +7.79%, while revenue for the quarter reached $1.08B , beating expectations by +2.68%.
Earnings released on 21 Apr 2022
EPS came in at $2.63 surpassing the estimated $2.38 by +10.50%, while revenue for the quarter reached $1.13B , beating expectations by +7.26%.
Earnings released on 17 Feb 2022
EPS came in at $2.45 surpassing the estimated $2.42 by +1.24%, while revenue for the quarter reached $1.05B , beating expectations by +3.64%.
Dividend declared on 14 Feb 2022
A dividend of $1.37 per share was announced, adjusted to $1.46. The dividend was paid on 30 Mar 2022.
Earnings released on 20 Oct 2021
EPS came in at $2.55 surpassing the estimated $2.37 by +7.59%, while revenue for the quarter reached $1.04B .
Earnings released on 21 Jul 2021
EPS came in at $2.38 surpassing the estimated $2.20 by +8.18%, while revenue for the quarter reached $994.36M .
Earnings released on 21 Apr 2021
EPS came in at $2.13 surpassing the estimated $1.69 by +26.04%, while revenue for the quarter reached $930.48M .
Earnings released on 18 Feb 2021
EPS came in at $1.54 , while revenue for the quarter reached $804.08M .
Dividend declared on 16 Feb 2021
A dividend of $0.82 per share was announced, adjusted to $0.82. The dividend was paid on 31 Mar 2021.
Earnings released on 20 Oct 2020
EPS came in at $1.49 , while revenue for the quarter reached $731.69M .
SARTF Stock Performance
Access detailed SARTF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.